Dr. Donington is a Professor in Surgery and chief of the section of Thoracic Surgery. Her clinical and interests focus on the diagnosis and treatment of non-small cell lung cancer. Areas of expertise include the use of multimodality therapy for locally advanced lung cancer, treatment options for high-risk patients with early stage lung cancer and lung cancer in women. She is the surgical chair for the thoracic malignancy group of NRG Oncology Group, council member for the Western Thoracic Surgical Association, and immediate past-president of the New York Society for Thoracic Surgery, and the Women in Thoracic Surgery.
NYU
New York, NY
MS - Clinical Research
2010Mayo Hospital and Clinics
Rochester, MN
- Cardiothoracic Surgery
2002Georgetown University
Washington, DC
- General Surgery
1999NIH/NCI/Surgery Branch
Bethesda, MD
- Surgical Oncology
1996Rush University
Chicago, IL
MD - Medicine
1992University of Michigan
Ann Arbor, MI
BS - Biology
1987STS Policy for Respectful Scholarly Discourse: Providing a Framework for Professional Behavior at Academic Conferences.
STS Policy for Respectful Scholarly Discourse: Providing a Framework for Professional Behavior at Academic Conferences. Ann Thorac Surg. 2024 Oct 21.
PMID: 39442903American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy.
American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy. J Thorac Oncol. 2024 Dec; 19(12):1654-1667.
PMID: 39313150Appropriate Use Criteria (AUC) for Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Executive Summary of the American Radium Society's Systematic Review and Guidelines.
Appropriate Use Criteria (AUC) for Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Executive Summary of the American Radium Society's Systematic Review and Guidelines. J Thorac Oncol. 2024 Sep 11.
PMID: 39271016Implementing a Frailty-Specific Postoperative Order Set to Improve Postoperative Outcomes in Frail Adults After Elective Thoracic Surgery.
Implementing a Frailty-Specific Postoperative Order Set to Improve Postoperative Outcomes in Frail Adults After Elective Thoracic Surgery. J Nurs Care Qual. 2024 Oct-Dec 01; 39(4):361-368.
PMID: 38936412Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center.
Cost effectiveness of commercial portable ex vivo lung perfusion at a low-volume US lung transplant center. Artif Organs. 2024 Nov; 48(11):1288-1296.
PMID: 38924545American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer.
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer. JAMA Oncol. 2024 Jun 01; 10(6):799-806.
PMID: 38602670Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility. J Clin Oncol. 2024 Jun 10; 42(17):2026-2037.
PMID: 38537159Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer.
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Jul; 25(5):440-448.
PMID: 38627155Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy.
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy. J Thorac Cardiovasc Surg. 2023 Dec 12.
PMID: 38092284The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.
View All Publications
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2023 Dec 07.
PMID: 38070600